Infants of diabctic mothers have an increased incidence of both arterial and venous thromboses. Oppenheimer and Esterly (1) rcportcd a 15.8% incidence of venous thrombosis in 45 newborn infants of diabctic mothcrs. licnal vein thrombosis is the most common thrombotic complication in infants of diabetic mothers (2, 3) . More recently, Van Allen et (11. (4) first reported an infant of a diabetic mother with an it7 lrtero brachial artcry thrombosis and neonatal gangrene who developed postnatal aortic and mcsenteric artery thrombosis. After review of the literature. they found that 7 of 32 infants with neonatal gangrene of a limb presenting at birth wcrc infants of diabctic mothers. David et (11. (5) reported a case of oromandibular limb hypogenesis thought to be associated with an intrauterine vascular accident in an infant of a diabetic mother.
'l'hc hemostatic alterations predisposing to thrombosis and the specific factors responsible for these alterations arc unclear. I-Icmostatic alterations found in infants of diabctic mothcrs who cxpericncc a thrombotic event could simply be secondary to the thrombotic cvent. There could also be primary altcrations of the normal development of homeostasis in thcsc infants exposed to both liyperglycemia and hypcrinsulincmia during intrauterine life leading to a hypercoagulablc state. The chronically catheterized fetal lamb provides a model whereby insulin-treated twins. There were relative increases in tihrinogen factors V, VII, and XI when the insulin-treated group was compared with the controls. .fhe changes arc consistent with an increased risk of thrombosis and may explain, in part, the higher incidence of thronlbosis in infants of diabctic mothers. (Pediatr Kes 38: 169-172, 1995) Abbreviations I),W, dextrose 5% in water solution WBC, white blood cell the intrauterine cnvironmcnt can be altered and the eDTects measured. Using twin lamb fetuses, it is possible to modify the environment of one fetus while allowing the other fetus to serve as control. This model was uscd successfully in studies of the eifects of glucocorticoids and thyroxin on the development of henlostasis in the fetus (6, 7) . W e havc, therefore, undertaken similar studies to measure the effects of hypcrinsulincmia on the dcvclopmcnt of hemostasis in fetal lambs during the last trimester of pregnancy.
METHODS
Pregnant mixed-breed Dorsct-Suffolk ewes werc obtained from existing sources and wcre housed throughout the study at the University of Iowa Animal Quarters. The gestational ages of the fctiiscs were known on the basis of induced ovulation technique (8) . Before surgery the cwcs wcrc fastcd for 4 8 h. Anesthesia of the ewe and surgery on the fetus were perfornlcd as described previously (9) .
'I'en pregnant cwcs cach with twin pregnancies wcrc uscd in this study. 'l'hc gestational ages of the twins averaged 120 d (109-130 d). Twins were used to control for natural intrauterine environmental differences. Both fetuses in each pregnant ewe wcre catheterized. Arterial and venous catheters were placed in the femoral arteries and veins of cach of the twins. After a 5-d rest period, one of each set of twins was infused i.v.
with insulin in I),W at a ratc of 2.5 U/h for 48 h. The twin sibling was infused with an cqual volume (10 mI,/24 11) of 170 KISKER AND MANCO-JOHNSON D,W. Constant infusion pumps (Cormed, Inc., Middleport, NY) werc used for the infusions. Both micropumps were housed in pockets of special jackets designed by our laboratory which allow the ewes complete freedom of movement during the infusions.
Before and at the completion of the infusions at 48 h, fetal blood samples were obtained through the chronically placed catheters for measurements of coagulation factor activities in both test asid control fetuses. A 7-mL aliquot of blood was obtained from each fetus with each phlebotomy. All samples werc collected in plastic, and samples for measurement of coagulation factor activities were diluted 9 parts of blood to 1 part of 0.01 M sodium citrate, pH 5.0. Blood samples were centrifuged at 1800 X g for 30 min; the supernatant plateletpoor plasma was removed, stored at -70°C in aliquots, and thawed just before measurcment of clotting factor activities.
Standard tcchniques wcrc used for measuring thc prothrombin time (10) and the partial thromboplastin time (11) . Specific factor activitics 11, V, VII, VIII, IX, X, XI, and XI1 were assayed with the one-stage assays measuring thc ability of the test plasma to correct plasma known to be deficient in the factors tested (12) . Fibrinogen was measured by thrombin clotting time according to the method of Clauss (13) . Human deficient plasmas were used, and an adult sheep standard pool consisting of plasma from 10 normal nonpregnant ewes was used for calibration. Antithrombin 111 was measured by the method of Henriksen and Owen (14). Plasminogen was measured using the amidolytic method described by Mussoni et al.
(15). Protein C activity was measured as described with Laurel1 rocket immunoelectrophoresis using a monospccific polyclonal rabbit anti-ovine protcin C antibody (our unpublished experiment). Fibrin monomer was measured by the method of Kisker (16). All activities measured are quoted as percentage of the reference standard pool of sheep plasma. Insulin lcvels were measured by RIA kit (Diagnostic Products Corp., Los Angeles, CA). The hemoglobin, hematocrit, and WBC count were measured with a Coulter model S (Coulter Electronics, Inc., Hialeah, FL) on a 0.5-mL aliquot of blood that was anticoagulatcd with EDTA. Platelet counts werc measured by phase microscopy on this EDTA sample.
The differences before and after insulin or saline infusion in each group and the differences between groups before and after insulin or saline infusions were statistically analyzed using paired t tests.
RESULTS
In Table 1 are presented the means and standard deviations of coagulation factor activities, hematocrit, WBC counts, platelet counts, insulin levels, and serum glucose concentrations before and after insulin infusion in control and treated twin pairs. The p values for the differences before and after treatment in each group are presented and the between group before and after treatment p values are also included. Figure 1 shows that protein C significantly decreased after insulin infusion in the insulin treated group. In the insulintreated animals, as shown in Figure 1 , the level of protein C decreased from 64 to 44% ( p = 0.003), whereas in the control animals the level decreased from 66 to 56% (p = 0.141). The between group differences did not, however, reach statistical significance (p = 0.0895). As expectcd, insulin also showed a statistically significant increase within the insulin-treated group -ppp- Fibrinogen and factors V, VII, and XI significantly increased in the insulin-treated group when compared with the control group. There were, however, no significant changes in these factors within the insulin or control groups.
~

DISCUSSION
Blood coagulation factor activities, particularly the vitamin K-dependent factors including protein C, are low in newborn infants relative to adult standards (17-20). These deficiencies render the neonate at risk for developing either hemorrhage or thrombosis with minimal hemostatic stress.
Previous studies using a fetal lamb model have shown that the patterns of development of blood coagulation factor activities in the model are similar to those identified in the human infant (9) . Major increases in many of the blood coagulation factor activities occur toward the end of the last trimester of pregnancy (9) . Hormones may influence the normal patterns of development of coagulation factor activities and thus increase the likelihood of hemorrhage or thrombosis in the newborn. We previously reported a study of the effects of a 48-h infusion of glucocorticoids in the fetal lamb model. In this study, a 48-h exposure to increased glucocorticoids accelerated the development of coagulation factors (11, V, VII, IX, and X). More recently, a study of the effects of thyroxin demonstrated decreases in factor V and VII and increases in factor XI1 in thyroxin-treated fetal lambs (7) .
A number of physiologic disorders in infants of diabetic mothers have been suggested as possible contributing factors to the development of thrombosis in these infants. These disorders include dehydration, polycythemia, increased platelet prostaglandin synthesis, and decreased fibrinolysis (1, 21, 22) . A decrease in the anticoagulant protein C has also been suggested as potential factor leading to thrombosis. In a recent prospective survey of 193 newborn infants, protein C levels <0.1 U/mL were found in preterm infants with respiratory distress, infants of diabetic mothers, and infants of twin gestations (23). A protein C level <O.l U/mL correlated with the subsequent onset of thrombosis even when the effects of gestational age and birth weight were excluded.
In the current studies fetal lambs were exposed to hyperinsulinemia using the protocol that had previously been successful in demonstrating changes in blood coagulation factors in was no decrease in the hematocrit to suggest dilutional changes. The relative increases in fibrinogen and factors V, VII, and XI coupled with the low protein C levels all tend to shift the balance of hemostasis toward thrombosis. There were no counterbalancing decreases in the levels of other procoagulants or increases in the levels of other anticoagulants in the insulin-treated group which would shift the balance toward hemorrhage.
Unfortunately, not all factors predisposing to thrombosis could be measured in this experimental model. Because of the limitations on the volume of sample available, we were not able to measure the levels of free protein S, a cofactor of protein C. An increase in tissue factor pathway inhibitor might counterbalance the relatively increased levels of factors V and VII in the insulin-treated i~nimals, but we were also unable to measure tissue factor pathway inhibitor in the fetal lambs. Despite these deficiencies, the findings demonstrated that exposure of the fetus in utero to hyperinsulinemia for 48 h results in alterations of the balance of hemostasis toward thrombosis. 
